Which adverse effect requires monitoring with ganciclovir?

Prepare for the NLN Pharmacology Test. Practice with flashcards and multiple choice questions, complete with hints and explanations. Ace your exam with confidence!

Multiple Choice

Which adverse effect requires monitoring with ganciclovir?

Explanation:
Bone marrow suppression is the adverse effect to monitor with ganciclovir. This antiviral can affect rapidly dividing cells, including bone marrow precursors, leading to neutropenia, anemia, and thrombocytopenia. Because these cytopenias raise infection risk and can cause bleeding or fatigue, regular blood count monitoring is essential. Start with a baseline CBC before therapy and check counts regularly during treatment (often weekly or per protocol), adjusting the dose or stopping treatment if counts drop significantly. Monitoring renal function is also important since ganciclovir is excreted renally and may require dose adjustments in kidney impairment. Other listed adverse effects are not the primary toxicities that drive the need for routine hematologic monitoring.

Bone marrow suppression is the adverse effect to monitor with ganciclovir. This antiviral can affect rapidly dividing cells, including bone marrow precursors, leading to neutropenia, anemia, and thrombocytopenia. Because these cytopenias raise infection risk and can cause bleeding or fatigue, regular blood count monitoring is essential. Start with a baseline CBC before therapy and check counts regularly during treatment (often weekly or per protocol), adjusting the dose or stopping treatment if counts drop significantly. Monitoring renal function is also important since ganciclovir is excreted renally and may require dose adjustments in kidney impairment. Other listed adverse effects are not the primary toxicities that drive the need for routine hematologic monitoring.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy